[go: up one dir, main page]

MY177020A - Compositions and methods for maintaining bone heal th or reducing bone loss - Google Patents

Compositions and methods for maintaining bone heal th or reducing bone loss

Info

Publication number
MY177020A
MY177020A MYPI2010004980A MYPI2010004980A MY177020A MY 177020 A MY177020 A MY 177020A MY PI2010004980 A MYPI2010004980 A MY PI2010004980A MY PI2010004980 A MYPI2010004980 A MY PI2010004980A MY 177020 A MY177020 A MY 177020A
Authority
MY
Malaysia
Prior art keywords
bone
compositions
methods
heal
maintaining
Prior art date
Application number
MYPI2010004980A
Inventor
Linda May Schollum
Marlena Cathorina Kruger
Wei-Hang Chang
Original Assignee
Fonterra Cooperative Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fonterra Cooperative Group Ltd filed Critical Fonterra Cooperative Group Ltd
Publication of MY177020A publication Critical patent/MY177020A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Use of a water soluble extract of rosehip for the maintenance or improvement of bone health or bone strength and to treat or prevent bone disorders characterised by weakened or fragile bones. The invention also relates to compositions comprising a water soluble extract of rosehip useful for the maintenance or imrpovement of bone health or bone strength and to treat or prevent bone disorders characterised by weakened or fragile bones.
MYPI2010004980A 2008-04-24 2009-04-23 Compositions and methods for maintaining bone heal th or reducing bone loss MY177020A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ567712A NZ567712A (en) 2008-04-24 2008-04-24 Compositions and methods for maintaining bone health or reducing bone loss

Publications (1)

Publication Number Publication Date
MY177020A true MY177020A (en) 2020-09-01

Family

ID=41217023

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010004980A MY177020A (en) 2008-04-24 2009-04-23 Compositions and methods for maintaining bone heal th or reducing bone loss

Country Status (5)

Country Link
CN (1) CN102065877B (en)
MY (1) MY177020A (en)
NZ (1) NZ567712A (en)
TW (1) TWI454273B (en)
WO (1) WO2009131470A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2562837C1 (en) * 2014-06-03 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Воронежский государственный университет инженерных технологий (ФГБОУ ВПО ВГУИТ) Method for production of sauce based on colostrum protein concentrate
US11425915B2 (en) 2018-05-02 2022-08-30 Land O'lakes, Inc. Methods of concentrating phospholipids
US12161131B2 (en) 2018-12-20 2024-12-10 Land O'lakes, Inc. Cheese sauce
CN113396984A (en) * 2021-06-17 2021-09-17 优贺普食品(上海)有限公司 Children milk powder with two formulas at day and night and packaging form
CN116585300B (en) * 2023-05-30 2024-04-19 苏州大学附属第一医院 Application of cynarin in the preparation of drugs for preventing or treating steroid-induced femoral head necrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024960A (en) * 1998-04-17 2000-02-15 Otto Torbjorn Hansen And Marianne Hansen Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
US7084122B2 (en) * 2001-11-21 2006-08-01 Erik Larsen Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents
US20090209746A1 (en) * 2006-07-03 2009-08-20 Hyben Vital Licens Aps Method of Preparing a Glycoside of a Mono or Diacylglycerol Product From a Plant Material
EP2049134A2 (en) * 2006-07-14 2009-04-22 DSMIP Assets B.V. Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases

Also Published As

Publication number Publication date
NZ567712A (en) 2010-11-26
CN102065877B (en) 2013-06-19
HK1155675A1 (en) 2012-05-25
WO2009131470A1 (en) 2009-10-29
TWI454273B (en) 2014-10-01
CN102065877A (en) 2011-05-18
TW200946125A (en) 2009-11-16

Similar Documents

Publication Publication Date Title
HK1221171A1 (en) Compositions for use in stimulating bone growth
WO2008130989A3 (en) Prosthetic implants
WO2011019822A3 (en) Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
EP2440209A4 (en) Compositions and methods for the prevention and treatment of heart failure
MX350761B (en) Isoindolinone inhibitors of phosphatidylinositol 3-kinase.
MY159856A (en) Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
MY152282A (en) Compositions and methods for use antibodies against sclerostin
IL194865A0 (en) Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
WO2007092622A3 (en) Compositions and methods for treating bone
PL2139434T3 (en) Implant sysrem for fastening an implant to bone tissue
EP2129683A4 (en) Methods and compositions for the treatment of heart failure and other disorders
MX2009005725A (en) Methods and compositions for treating and monitoring treatment of il-13-associated disorders.
IL219160A0 (en) Novel compositions for preventing and/or treating degenerative disorders of the central nervous system
MX2010007490A (en) Preparation of sulfamide derivatives.
IN2012DN02624A (en)
WO2012140167A3 (en) A fixture, a thread maker and a fixture set
MX2010006081A (en) A healthy drink and a method for improving stability of a drink.
EP2490721A4 (en) Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
MY177020A (en) Compositions and methods for maintaining bone heal th or reducing bone loss
WO2011147034A8 (en) Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereof
MX2011008645A (en) Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase.
IN2012DN03187A (en)
WO2011041325A3 (en) Methods and compositions for the treatment of viral disorders
GB0917745D0 (en) Compositions for the prevention or treatment of migraine
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives